Back to All

Peter Keeling interview: Owning the diagnostic journey

3 October, 2017

Diaceutics CEO, Peter Keeling, recently shared insights into the company's achievements in precision medicine in an interview with the Irish Examiner. Under Keeling's leadership, Diaceutics has become a prominent player in the healthcare industry, specializing in diagnostic testing for precision medicine.

Keeling highlighted the pivotal role of accurate diagnostic testing in ensuring patients receive the most effective treatments. He emphasized the importance of collaboration between pharmaceutical companies, diagnostic laboratories, and healthcare providers to streamline the testing process and improve patient outcomes.

Click here to view the full article and learn more. 

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny